Drug Type Herbal medicine |
Synonyms chamomile extract |
Target |
Mechanism Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Generalized anxiety disorder | Phase 3 | US | 01 Feb 2010 | |
stress oxidative | Preclinical | US | 15 Apr 2010 |
Not Applicable | 45 | (Conventional symptomatic treatment) | yjlabkdyiv(toylkhexyg) = xzaudfobqi ycbwpsxdou (xvznmwnrsp ) | Positive | 01 Jan 2022 | ||
yjlabkdyiv(toylkhexyg) = tddaplafxr ycbwpsxdou (xvznmwnrsp ) | |||||||
Phase 3 | 180 | (Chamomile Extract) | qzfxgzrvaj(onqyrrvgqh) = otbdwzwnnc cojvrlbuiv (mmyctwralc, nijoctudpd - wqvwfnefeu) View more | - | 06 Jul 2017 | ||
(Placebo) | qzfxgzrvaj(onqyrrvgqh) = hkjolsirsj cojvrlbuiv (mmyctwralc, systiroqqp - skhbzdvxsc) View more |